2 not yet recruiting, 2 withdrawn, 1 completed, 1 unknown. 6 Phase 3, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Not yet recruiting 2, Withdrawn 2, Completed 1, Unknown 1 |
| Phase 2 | 5 | Not yet recruiting 2, Withdrawn 2, Unknown 1 |
Follow testosterone cypionate: new trials by email Literature Review of testosterone cypionate trials Research Report on testosterone cypionate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testosterone Therapy With or Without Finasteride After Spinal Cord Injury: TRT-SCI Trial testosterone cypionate, finasteride, placebo injection - Spinal Cord Injury, Spinal Cord Injuries | Phase 2 / Phase 3 | Not yet recruiting | VA Office of Research and Development | 300 | 2027-10-01 | 2026-08-04 |
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair Testosterone cypionate, Placebos - Rotator Cuff Tears | Phase 2 / Phase 3 | Withdrawn | Orthopedic Institute, Sioux Falls, SD | 2021-08-01 | 2022-03-15 | |
| Role of Anabolic Steroids on Intensive Care Unit-Acquired Weakness Testosterone cypionate, Standard nutrition and physical therapy at ICU - Critical Illness Polyneuropathies | Phase 2 / Phase 3 | Unknown | Hospital de Clinicas de Porto Alegre | 30 | 2016-10-01 | 2017-02-01 |
| Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction Testosterone, Normal Saline - Hypogonadism, Acute Myocardial Infarction: Rehabilitation Phase | Phase 2 / Phase 3 | Withdrawn | Texas Tech University Health Sciences Center | 2016-08-01 | 2019-11-21 | |
| Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients Testosterone, Placebo - Advanced Cancer | Phase 3 | Completed | M.D. Anderson Cancer Center | 53 | 2009-09-01 | 2016-09-13 |
Hypogonadism (2) · Bone Diseases (1) · Bone Resorption (1) · Central Nervous System Diseases (1) · Endocrine System Diseases (1) · Fatigue (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Gonadal Disorders (1) · Male Urogenital Diseases (1) · Motor Activity (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Nervous System Diseases (1) · Polyneuropathies (1)
ECOG-ACRIN Cancer Research Group (1) · Hospital de Clinicas de Porto Alegre (1) · M.D. Anderson Cancer Center (1) · Orthopedic Institute, Sioux Falls, SD (1) · Texas Tech University Health Sciences Center (1) · VA Office of Research and Development (1)
United States (4) · Brazil (1)
Craig W Spellman, DO (1) · Joshua F Yarrow, PhD MS BS (1) · Keith M Baumgarten, MD (1) · Michael Schweizer (1) · Osama Mukarram, MD (1) · Rony Dev, DO (1) · Sandeep Dhindsa, MD (1) · Silvia RR Vieira, PhD (1)
U10CA180820 (1)